Inactive Instrument

Carmat Stock Other OTC

Medical Equipment, Supplies & Distribution

Analysts' recommendations: Carmat

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

03-04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
01-07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
01-07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
01-07	CARMAT : A suivre aujourd'hui
01-07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	6.15M 7M 5.72M 5.24M 9.85M 674M 10.01M 67.87M 26.52M 331M 26.27M 25.7M 1.15B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.46M 55.1M 50.56M 95M 6.5B 96.46M 654M 256M 3.19B 253M 248M 11.04B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
01-07	CARMAT: To Watch Today
01-06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
01-06	Carmat Announces Liquidation and Delisting
12-02	Only Takeover Bid for Carmat Approved by Court
12-02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
12-02	Carmat receives takeover bid	RE
11-04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
25-10-01	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

12-02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
11-04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	7.08M
STRYKER CORPORATION	+3.54%	+3.25%	-16.74%	+13.59%	127B
SMITH & NEPHEW PLC	+1.92%	-0.96%	-2.69%	-5.12%	12.79B
GLAUKOS CORPORATION	+0.95%	-2.07%	+62.73%	+110.30%	9.02B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-6.12%	-1.94%	-49.75%	-68.94%	4.39B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.21%	-2.71%	-0.62%	+35.02%	2.63B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.59%	-0.76%	-18.40%	-26.34%	1.59B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-3.05%	-2.46%	-26.43%	-31.81%	1.58B
ENOVIS CORPORATION	+3.72%	-0.15%	-0.48%	-57.80%	1.56B
Average	-0.20%	-1.57%	-6.55%	-3.89%	20.02B
Weighted average by Cap.	+2.81%	+2.38%	-11.74%	+14.09%

	2023	2024
Net sales	3.84M 4.37M 3.57M 3.27M 6.15M 421M 6.25M 42.37M 16.55M 207M 16.4M 16.05M 715M	7.34M 8.36M 6.83M 6.27M 11.78M 805M 11.96M 81.1M 31.69M 396M 31.39M 30.71M 1.37B
Net income	-53.87M -61.33M -50.1M -45.97M -86.38M -5.91B -87.71M -595M -232M -2.9B -230M -225M -10.04B	-51.4M -58.52M -47.8M -43.86M -82.41M -5.64B -83.68M -568M -222M -2.77B -220M -215M -9.58B
Net Debt	49.64M 56.51M 46.16M 42.36M 79.59M 5.44B 80.81M 548M 214M 2.68B 212M 208M 9.25B	53.1M 60.46M 49.38M 45.31M 85.14M 5.82B 86.45M 586M 229M 2.86B 227M 222M 9.9B

Carmat Stock Other OTC

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news : Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile